Skip to main content
Premium Trial:

Request an Annual Quote

GenUs Biosystems Launches as DNA Microarray Service Lab

NEW YORK, Aug. 18 (GenomeWeb News) - GenUs Biosystems said today it has launched as a DNA microarray service laboratory.

 

The company, based in Chicago, was founded by Scott Magnuson, a senior applications consultant for CodeLink at Amersham Biosciences, and prior to that, at Motorola Life Sciences. John Callaci., the chief scientific officer and research associate at Loyola Medical center' and Michael Falduto, the chief technology officer and a senior scientist with Abbott Laboratories, are the co-founders.

 

GenUs will conduct gene expression profiling services for clients, including sample preparation, analysis of sample quality, processing of RNA and DNA provided by customers, and data analysis.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.